Cogent Biosciences, Inc. (COGT)
32.14
+1.23
(+3.98%)
USD |
NASDAQ |
Oct 27, 11:50
Cogent Biosciences Market Cap : 5.517B for Oct. 27, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 26, 2026 | 5.305B |
| October 23, 2026 | 5.357B |
| October 22, 2026 | 5.374B |
| October 21, 2026 | 5.395B |
| October 20, 2026 | 5.362B |
| October 19, 2026 | 5.151B |
| October 16, 2026 | 5.067B |
| October 15, 2026 | 5.065B |
| October 14, 2026 | 4.832B |
| October 13, 2026 | 4.821B |
| October 12, 2026 | 5.112B |
| October 09, 2026 | 5.321B |
| October 08, 2026 | 5.163B |
| October 07, 2026 | 5.173B |
| October 06, 2026 | 5.214B |
| October 05, 2026 | 5.299B |
| October 02, 2026 | 5.324B |
| October 01, 2026 | 5.422B |
| September 30, 2026 | 5.496B |
| September 29, 2026 | 5.434B |
| September 28, 2026 | 5.469B |
| September 25, 2026 | 5.546B |
| September 24, 2026 | 5.395B |
| September 23, 2026 | 5.391B |
| September 22, 2026 | 5.601B |
| Date | Value |
|---|---|
| September 21, 2026 | 5.493B |
| September 18, 2026 | 5.407B |
| September 17, 2026 | 5.697B |
| September 16, 2026 | 5.585B |
| September 15, 2026 | 5.620B |
| September 14, 2026 | 5.735B |
| September 11, 2026 | 5.735B |
| September 10, 2026 | 5.850B |
| September 09, 2026 | 5.867B |
| September 08, 2026 | 6.056B |
| September 04, 2026 | 5.966B |
| September 03, 2026 | 5.999B |
| September 02, 2026 | 5.934B |
| September 01, 2026 | 5.953B |
| August 31, 2026 | 6.007B |
| August 28, 2026 | 5.951B |
| August 27, 2026 | 6.366B |
| August 26, 2026 | 6.303B |
| August 25, 2026 | 6.316B |
| August 24, 2026 | 6.219B |
| August 21, 2026 | 6.304B |
| August 20, 2026 | 6.061B |
| August 19, 2026 | 6.325B |
| August 18, 2026 | 6.419B |
| August 17, 2026 | 6.500B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Moderna, Inc. | 78.12B |
| Arrowhead Pharmaceuticals, Inc. | 8.491B |
| Oncolytics Biotech, Inc. | 60.70M |
| Sangamo Therapeutics, Inc. | 48.10M |
| Sarepta Therapeutics, Inc. | 1.956B |
Market Cap Related Metrics
| Price to Book Value | 11.80 |
| Price | 32.14 |
| Earnings Yield | -7.61% |